Hotchkis & Wiley Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$415M Sell
4,791,090
-29,614
-0.6% -$2.84M 1.28% 25
2025
Q4
$463M Sell
4,820,704
-1,001,283
-17% -$97.3M 1.38% 22
2025
Q3
$554M Sell
5,821,987
-109,934
-2% -$10.1M 1.71% 14
2025
Q2
$517M Sell
5,931,921
-296,385
-5% -$25.1M 1.68% 14
2025
Q1
$560M Sell
6,228,306
-1,392,226
-18% -$125M 1.87% 13
2024
Q4
$609M Buy
7,620,532
+838,082
+12% +$72.6M 2.03% 8
2024
Q3
$611M Sell
6,782,450
-396,725
-6% -$33.4M 2.03% 10
2024
Q2
$565M Sell
7,179,175
-63,124
-0.9% -$5.17M 1.97% 10
2024
Q1
$631M Buy
7,242,299
+1,005,267
+16% +$85.8M 2.1% 9
2023
Q4
$514M Buy
6,237,032
+1,318,590
+27% +$100M 1.83% 12
2023
Q3
$385M Sell
4,918,442
-55,480
-1% -$4.64M 1.46% 24
2023
Q2
$438M Buy
4,973,922
+405,930
+9% +$34.9M 1.63% 18
2023
Q1
$368M Buy
4,567,992
+489,710
+12% +$39.9M 1.42% 23
2022
Q4
$317M Buy
4,078,282
+1,469,856
+56% +$119M 1.22% 26
2022
Q3
$211M Sell
2,608,426
-46,500
-2% -$4.18M 0.9% 37
2022
Q2
$238M Sell
2,654,926
-243,243
-8% -$24.6M 0.95% 34
2022
Q1
$322M Sell
2,898,169
-340,840
-11% -$36M 1.02% 32
2021
Q4
$335M Buy
3,239,009
+301,230
+10% +$34.9M 1.05% 34
2021
Q3
$368M Sell
2,937,779
-117,250
-4% -$15.2M 1.18% 27
2021
Q2
$379M Sell
3,055,029
-650,982
-18% -$81.7M 1.16% 32
2021
Q1
$438M Sell
3,706,011
-105,000
-3% -$12.3M 1.33% 25
2020
Q4
$446M Buy
3,811,011
+49,950
+1% +$5.5M 1.56% 18
2020
Q3
$391M Sell
3,761,061
-445,652
-11% -$44.8M 1.77% 16
2020
Q2
$386M Buy
4,206,713
+34,865
+0.8% +$3.34M 1.79% 16
2020
Q1
$376M Sell
4,171,848
-140,910
-3% -$15M 2.11% 11
2019
Q4
$489M Buy
4,312,758
+373,706
+9% +$41M 1.7% 18
2019
Q3
$428M Sell
3,939,052
-666,230
-14% -$69.5M 1.72% 14
2019
Q2
$449M Buy
4,605,282
+487,742
+12% +$44.5M 1.72% 13
2019
Q1
$375M Buy
4,117,540
+1,385,936
+51% +$124M 1.47% 21
2018
Q4
$248M Sell
2,731,604
-452,295
-14% -$42.3M 1.1% 35
2018
Q3
$313M Sell
3,183,899
-443,726
-12% -$41M 1.12% 34
2018
Q2
$311M Sell
3,627,625
-235,200
-6% -$19.6M 1.17% 31
2018
Q1
$310M Buy
3,862,825
+1,381,928
+56% +$114M 1.23% 30
2017
Q4
$200M Buy
2,480,897
+244,100
+11% +$19.5M 0.76% 45
2017
Q3
$174M Buy
2,236,797
+9,200
+0.4% +$764K 0.69% 48
2017
Q2
$198M Buy
2,227,597
+991,800
+80% +$83.6M 0.79% 43
2017
Q1
$99.6M Sell
1,235,797
-15,554
-1% -$1.21M 0.39% 62
2016
Q4
$89.1M Buy
1,251,351
+238,419
+24% +$18.7M 0.36% 71
2016
Q3
$87.5M Sell
1,012,932
-640,730
-39% -$55.8M 0.37% 71
2016
Q2
$143M Sell
1,653,662
-720,349
-30% -$58.3M 0.61% 48
2016
Q1
$178M Sell
2,374,011
-1,506,903
-39% -$113M 0.75% 45
2015
Q4
$299M Sell
3,880,914
-1,409,536
-27% -$106M 1.21% 25
2015
Q3
$354M Sell
5,290,450
-329,058
-6% -$24.2M 1.42% 24
2015
Q2
$416M Sell
5,619,508
-133,508
-2% -$10.2M 1.47% 23
2015
Q1
$449M Buy
5,753,016
+2,545,132
+79% +$193M 1.56% 20
2014
Q4
$232M Sell
3,207,884
-23,074
-0.7% -$1.6M 0.81% 44
2014
Q3
$200M Buy
3,230,958
+1,298,458
+67% +$82.6M 0.73% 49
2014
Q2
$123M Sell
1,932,500
-134,300
-6% -$8.16M 0.44% 66
2014
Q1
$127M Buy
2,066,800
+326,000
+19% +$19M 0.47% 65
2013
Q4
$99.9M Sell
1,740,800
-8,500
-0.5% -$482K 0.43% 69
2013
Q3
$93.2M Sell
1,749,300
-8,747
-0.5% -$471K 0.43% 72
2013
Q2
$90.5M Buy
+1,758,047
New +$86.9M 0.45% 69

Other funds holding MDT

Hotchkis & Wiley Capital Management's MDT Position: Q1 2026 in Review

Hotchkis & Wiley Capital Management reduced its Medtronic (MDT) stake by 0.61% in Q1 2026, selling an estimated $2.84M and leaving 4,791,090 shares worth $415M. The position accounts for 1.28% of the portfolio, ranked #25.

Hotchkis & Wiley Capital Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $631M in Q1 2024. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Hotchkis & Wiley Capital Management held 4,791,090 shares of Medtronic worth $415M as of Q1 2026.
  • Hotchkis & Wiley Capital Management sold 29,614 Medtronic shares in Q1 2026, an estimated $2.84M.
  • Medtronic made up 1.28% of Hotchkis & Wiley Capital Management's portfolio in Q1 2026, its #25 holding.
  • Hotchkis & Wiley Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Hotchkis & Wiley Capital Management's Medtronic position peaked at $631M in Q1 2024.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q1 2026, filed 15 May 2026.